Solving A Lackluster Growth Outlook Should Be Solventum's Next Priority

Solving A Lackluster Growth Outlook Should Be Solventum's Next Priority

Management targets 3–4% underlying revenue growth for 2026, with SOLV EPS likely at the high end of the $6.40–$6.60 range. Restructuring and portfolio optimization offer significant upside, as SOLV’s business units lack natural synergies and could be divested. SOLV stock valuation remains attractive, with DCF and EV/revenue suggesting 20%+ upside, but patient investors are required given slow growth.

The market performance of Solventum Corporation (SOLV) continues to be a “good news / bad news” sort of proposition. While the shares are down about 5% since my last update, that’s actually noticeably This article was written by Stephen Simpson